
|Videos|May 24, 2013
The Financial Footprint of a Specialty Patient
Einodshofer explains how the costs associated with one specialty patient's treatment can have the same financial footprint as an entire population of patients. Video from PBMI's Drug Benefit Conference 2013.
Advertisement
Einodshofer explains how the costs associated with one specialty patient's treatment can have the same financial footprint as an entire population of patients. Video from PBMI's Drug Benefit Conference 2013.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Fast Tracks First-in-Class TNFR2 Antibody as Chemotherapy-Free Strategy for Platinum-Resistant Ovarian Cancer
2
Beat the Heat: 10 Common Medication Culprits Causing Heat Intolerance
3
Yes, COVID-19 Is Still a Big Deal. Pharmacy Is the Tip of the Spear (and Needle)
4
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
5




































































































